Principal Investigator

Umesh Ramanlal
Desai
Awardee Organization

Virginia Commonwealth University
United States

Fiscal Year
2021
Activity Code
U01
Project End Date

Tool for Predicting Glycosaminoglycan Recognition of Proteins

GAGs present considerable structural diversity, which has made the study of individual GAG sequences humanly impossible. Most studies performed to date rely on heterogeneous GAG compositions, such as heparin and chondroitin sulfate. Few dozen GAG oligosaccharides have become commercially available in recent times (Sigma (US), Dextra (UK), and Iduron (UK)). Yet, purchasing even a small, reasonably diverse library of these oligosaccharides is very expensive (~$200–300 for few µg to mg each). More importantly, the oligosaccharides available from these companies are generally the common sequences and do not represent the diversity present in nature. Synthesis of GAG oligosaccharides is challenging and only a handful of groups have experience with synthesis technology. We have developed a computational tool that helps predict key GAG sequence that recognize protein with high affinity. Our tool has been validated for proteins including antithrombin, fibroblast growth factor-1 & its receptor (FGF-1/FGFR1), transforming growth factor 2 (TGF2), thrombin, histone acetyltransferase p300, human neutrophil elastase and chemokine CXCL13. We propose to make this tool freely available to the research community so that many groups can computationally assess whether their protein of interest binds GAGs. Our two aims include 1) develop a graphical user interface (GUI) on a web-server to enable researchers utilize our computational tool for studying GAG–protein interactions; and 2) advance the computational tool for predicting the interaction of commercially available GAG sequences (HP/HS and CS/DS) with proteins. These two aims directly address the RFA by making our in-house tool “significantly more straightforward and accessible for non-specialists”. In terms of output, this work will put forward a webenabled tool carrying libraries of GAG sequences and appropriate algorithms for use by researchers from remote sites. It will add to the continuing democratization of glycan tools to enable more effective glycan research. In terms of knowledge contribution, our computational tool would help enhance understanding on how GAGs are recognized by proteins, especially those belonging to coagulation, inflammation and growth/morphogenesis systems.

Publications

  • Holmes SG, Desai UR. Assessing Genetic Algorithm-Based Docking Protocols for Prediction of Heparin Oligosaccharide Binding Geometries onto Proteins. Biomolecules. 2023 Nov 9;13. (11). PMID: 38002315
  • Chittum JE, Sankaranarayanan NV, O'Hara CP, Desai UR. On the Selectivity of Heparan Sulfate Recognition by SARS-CoV-2 Spike Glycoprotein. ACS medicinal chemistry letters. 2021 Oct 8;12(11):1710-1717. doi: 10.1021/acsmedchemlett.1c00343. eCollection 2021 Nov 11. PMID: 34786180
  • Sankaranarayanan NV, Sistla S, Nagarajan B, Chittum JE, Lau JTY, Desai UR. Computational studies on glycosaminoglycan recognition of sialyl transferases. Glycobiology. 2023 Aug 14;33(7):579-590. PMID: 37171590
  • Nagarajan B, Sankaranarayanan NV, Desai UR. In-Depth Molecular Dynamics Study of All Possible Chondroitin Sulfate Disaccharides Reveals Key Insight into Structural Heterogeneity and Dynamism. Biomolecules. 2022 Jan 5;12. (1). PMID: 35053225
  • Tiwari V, Beer JC, Sankaranarayanan NV, Swanson-Mungerson M, Desai UR. Discovering small-molecule therapeutics against SARS-CoV-2. Drug discovery today. 2020 Aug;25(8):1535-1544. Epub 2020 Jun 20. PMID: 32574699
  • Nagarajan B, Holmes SG, Sankaranarayanan NV, Desai UR. Molecular dynamics simulations to understand glycosaminoglycan interactions in the free- and protein-bound states. Current opinion in structural biology. 2022 Jun;74:102356. Epub 2022 Mar 17. PMID: 35306321
  • Tiwari V, Tandon R, Sankaranarayanan NV, Beer JC, Kohlmeir EK, Swanson-Mungerson M, Desai UR. Preferential recognition and antagonism of SARS-CoV-2 spike glycoprotein binding to 3-O-sulfated heparan sulfate. bioRxiv : the preprint server for biology. 2020 Oct 8. PMID: 33052337
  • Kellogg GE, Cen Y, Dukat M, Ellis KC, Guo Y, Li J, May AE, Safo MK, Zhang S, Zhang Y, Desai UR. Merging cultures and disciplines to create a drug discovery ecosystem at Virginia commonwealth university: Medicinal chemistry, structural biology, molecular and behavioral pharmacology and computational chemistry. SLAS discovery : advancing life sciences R & D. 2023 Sep;28(6):255-269. Epub 2023 Feb 28. PMID: 36863508
  • Ponnuraj N, Akbar H, Arrington JV, Spatz SJ, Nagarajan B, Desai UR, Jarosinski KW. The alphaherpesvirus conserved pUS10 is important for natural infection and its expression is regulated by the conserved Herpesviridae protein kinase (CHPK). PLoS pathogens. 2023 Feb 7;19(2):e1010959. doi: 10.1371/journal.ppat.1010959. eCollection 2023 Feb. PMID: 36749787
  • Morla S, Desai UR. Discovery of Sulfated Small Molecule Inhibitors of Matrix Metalloproteinase-8. Biomolecules. 2020 Aug 9;10. (8). PMID: 32784891
  • Sankaranarayanan NV, Nagarajan B, Desai UR. Combinatorial Virtual Library Screening Study of Transforming Growth Factor-β2-Chondroitin Sulfate System. International journal of molecular sciences. 2021 Jul 14;22. (14). PMID: 34299163
  • Rajarathnam K, Desai UR. Structural Insights Into How Proteoglycans Determine Chemokine-CXCR1/CXCR2 Interactions: Progress and Challenges. Frontiers in immunology. 2020 Apr 24;11:660. doi: 10.3389/fimmu.2020.00660. eCollection 2020. PMID: 32391006
  • Abdelfadiel EI, Gunta R, Villuri BK, Afosah DK, Sankaranarayanan NV, Desai UR. Designing Smaller, Synthetic, Functional Mimetics of Sulfated Glycosaminoglycans as Allosteric Modulators of Coagulation Factors. Journal of medicinal chemistry. 2023 Apr 13;66(7):4503-4531. Epub 2023 Mar 31. PMID: 37001055